Maris Laboratory News & Announcements

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

1 - 6 of 6

In The News: STAT Madness, Autistic Adolescents, Invasive Candidiasis, Allergen Label Warnings, ASH 2022 Scholar Awards

Published on Mar 4, 2022 in Cornerstone Blog
Our Scientists’ Research Highlighted In the News
Learn about novel findings and new funding from our Children’s Hospital of Philadelphia researchers.

STAT Wunderkind "Blazing New Trails:" Q&A With Mark Yarmarkovich, PhD

Published on Dec 15, 2021 in Cornerstone Blog
Q&A With STAT Wunderkind Mark Yarmarkovich, PhD
Dr. Mark Yarmarkovich, PhD, a senior scientist at CHOP, is a 2021 STAT Wunderkind.

CHOP Researchers Develop a New Class of CAR-T Cells that Target Previously Untargetable Cancer Drivers

Published on Nov 3, 2021 in Press Releases
CHOP researchers have developed a novel cancer therapy that targets proteins inside cancer cells that are essential for tumor growth.

New Kind of CAR T-Cell Changes Scientists’ Approach to Solid Tumors

Published on Nov 3, 2021 in Cornerstone Blog
PC-CARs Target Tumor-Specific Peptides
The peptide-centric CAR T cells, or PC-CARS, target cancer drivers in tumor cells previously thought unreachable.

Dr. John Maris Receives QED Award to Develop Novel Treatment for Neuroblastoma

Published on Feb 7, 2019 in Press Releases
A leading physician-researcher at Children’s Hospital of Philadelphia (CHOP) has received an award from the QED Program of the University City Science Center to help develop an innovative T-cell based treatment for the childhood cancer neuroblastoma.

John Maris, MD, Receives National Cancer Institute Outstanding Investigator Award

Published on Feb 26, 2018 in Cornerstone Blog
John M. Maris, MD
John Maris, MD, distinguished neuroblastoma researcher at CHOP, received the the National Cancer Institute's prestigious Outstanding Investigator Award.
1 - 6 of 6